Jump to content
  • Latest Donations

  • Advertisemnt

  • 14 Questions about VA Disability Compensation Benefits Claims


    When a Veteran starts considering whether or not to file a VA Disability Claim, there are a lot of questions that he or she tends to ask. Over the last 10 years, the following are the 14 most common basic questions I am asked about ...
    Continue Reading
  • Ads

  • Most Common VA Disabilities Claimed for Compensation:   


  • Advertisemnt

  • Advertisemnt

  • Ads

  • Can a 100 percent Disabled Veteran Work and Earn an Income?

    employment 2.jpeg

    You’ve just been rated 100% disabled by the Veterans Affairs. After the excitement of finally having the rating you deserve wears off, you start asking questions. One of the first questions that you might ask is this: It’s a legitimate question – rare is the Veteran that finds themselves sitting on the couch eating bon-bons … Continue reading

Sponsored Ads

  • Searches Community Forums, Blog and more

  • Donation Box

    Please donate to support the community.
    We appreciate all donations!
  • Available Subscriptions


Grappling With Risks, Rewards Of Ms Drug

Recommended Posts

Grappling with risks, rewards of MS drug

Managing risk is part of everyday business. But how do you deal with fear? Fear management has been a key challenge at Biogen Idec for the...


The Boston Globe


Managing risk is part of everyday business. But how do you deal with fear?

Fear management has been a key challenge at Biogen Idec for the past four years, since a few patients taking the company's promising new multiple-sclerosis drug, Tysabri, unexpectedly developed a rare but potentially lethal brain disease.

Biogen Idec shares were crushed at the time, losing 43 percent of their value in a single day. Regulators pulled Tysabri off the market until they could figure out what to do. Biogen Idec was allowed to reintroduce the drug 16 months later, but everyone continued to struggle to understand an unusual puzzle of risk and reward.

Biogen Idec's quarterly financial report last week included some of its most upbeat news to date on Tysabri.

Chief Executive Jim Mullen told investors the drug was developing into a certified "blockbuster." The company said total sales exceeded $250 million, putting it on track to generate more than $1 billion a year in revenues (Biogen Idec shares rights to Tysabri with Elan and claimed only $188 million of total sales in the results).

Tysabri sales had increased by an impressive 27 percent during the quarter. More important, the pace of new patients starting to take the drug accelerated. About 262 patients started taking Tysabri weekly during the second quarter, compared with about 170 per week in previous periods.

Those gains weren't achieved in a bad-news vacuum. Three new cases of progressive multifocal leukoencephalopathy, a viral brain disease known as PML, were reported among Tysabri patients in the month of June alone. A total of 10 cases have been reported since Tysabri returned to the market in 2006.

Stock analyst Eric Schmidt of Cowen & Co. said the new PML cases would dampen the impact of higher Tysabri sales on Biogen Idec shares. But "it is clear that Tysabri's growth continues despite all the negative attention the drug receives on Wall Street," he wrote in a note to investors Thursday.

By the end of June, 43,000 patients were taking Tysabri to treat multiple sclerosis, about half of them in the United States. They accepted a PML risk that is unlikely but very serious. How rare the complication will be over longer treatment remains unknown.

Many patients take Tysabri because it makes a dramatic difference in their lives. The drug can help some patients slow the progression of disability and manage effects of multiple sclerosis, improving their lives to a degree that makes the longshot risk of PML worth taking.

Biogen Idec executives work hard to help patients reach that decision. They argue the potential side effect, which has affected 13 patients, isn't as deadly as previously feared and point to treatment. They plaster the marketplace with information.

"We have a significant advantage," says Michael Panzara, Biogen Idec's chief medical officer for neurology. "You're starting from a place that, despite a rare risk, you have a drug that clearly does for MS patients what no other drug can do."

function ebStdBanner0_DoFSCommand(command,args){try{command = command.replace(/FSCommand:/ig,"");if((command.toLowerCase()=="ebinteraction") || (command.toLowerCase()=="ebclickthrough"))gEbStdBanners[0].handleInteraction();}catch(e){}}try{ebStdBanner0_DoFSCom

mand(command,args);}catch(e){}What Tysabri needs is more time. A year from now, Biogen Idec will have more information about patients who have been on its drug for a year, or two years or three years. Larger pools of patients who have been using the drug for longer periods will help define how much of a risk Tysabri might pose.

Considering all the Wall Street focus on Tysabri, you might think the drug was Biogen Idec's big-money product. Not so. The company's other MS drug, Avonex, generates much more revenue. Rituxan, which treats rheumatoid arthritis and non-Hodgkin lymphoma, outsells Tysabri, too.

But Tysabri is an important part of the growth story. Success would be sweet, and failure would be a serious setback.

Overcoming fear of any kind is no easy proposition. The Biogen Idec experience with patients suggests it takes time and many small steps.

Copyright © 2009 The Seattle Times Company

SOURCE: http://seattletimes.nwsource.com/html/heal...btbiogen20.html

Share this post

Link to post
Share on other sites


Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

  • Ads

  • Ad

  • Latest News
  • Our picks

    • SHOW YOUR SUPPORT: Ad Free Subscriptions to the Forum available
      Ad free subscriptions are available for the forum. Subscriptions give you the forums ad free and help support the forum and site. Monthly $5 Annually $50 https://community.hadit.com/subscriptions/

      Every bit helps - Thank you.

      • 0 replies
    • Choosing a VA Disability Attorney Means Learning What Questions to Ask
      Choosing a VA Disability Attorney Means Learning What Questions to Ask. Chris Attig - Veterans Law Blog 

      <br style="color:#000000; text-align:start">How to Hire an Attorney For Your VA Claim or Appeal Free Guidebook available on the Veterans Law Blog

      I got an email the other day from a Veteran.  It had 2 or 3 sentences about his claim, and then closed at the end: “Please call me. So-and-so told me you were the best and I want your help.”

      While I appreciate the compliments, I shudder a little at emails like this.  For 2 reasons.

      First, I get a lot of emails like this.  And while I diligently represent my clients – I often tell them we will pursue their claim until we have no more appeals or until we win – I am most assuredly not the best.

      There are a LOT of damn good VA Disability attorneys out there.  (Most, if not all, of the best are members of the National Organization of Veterans Advocates…read about one of them, here)

      Second, I don’t want Veterans to choose their attorney based on who their friend thought was the best.  I want Veterans to choose the VA Disability attorney who is BEST for their case.

      In some situations, that may be the Attig Law Firm.

      But it may also be be Hill and Ponton, or Chisholm-Kilpatrick, or Bergman Moore.  Or any one of the dozens of other attorneys who have made the representation of Veterans their professional life’s work.

      There are hundreds of attorneys that are out there representing Veterans, and I’m here to tell you that who is best for your friend’s case may not be the best for your case.

      How do you Find the Best VA Disability Attorney for your Claim?

      First, you have to answer the question: do you NEED an attorney?

      Some of you don’t...
      • 1 reply
    • VA Emergency Medical Care
      VA Emergency Medical Care
      • 3 replies
    • Veterans Appeals Improvement and Modernization Act
      Veterans Appeals Improvement and Modernization Act
      • 0 replies
    • Thanks Berta for your help. I did receive my 100% today for my IU claim on 6/20/2018. It only took 64 days to complete and it is p&t. Thanks for your words of wisdom. 

Important Information

{terms] and Guidelines